文献速递骨质疏松与代谢性骨病创伤骨科

Geisinger高危骨质疏松门诊(HiROC):2013—2015年骨折联络服务绩效分析

Geisinger high-risk osteoporosis clinic (HiROC): 2013-2015 FLS performance analysis.
PubMed 文献 · Osteoporos Int · 2017-10-23

该研究回顾性分析Geisinger健康系统(GHS)高危骨质疏松门诊(HiROC)2013—2015年门诊511例与住院1279例低创伤脆性骨折患者的绩效指标,HiROC路径治疗率达75%,明显高于GHS初级保健的13.8%,但37.8%的患者失访,并识别出多个照护差距与障碍,提示需要持续开展骨折联络服务(FLS)。

要点

  • HiROC门诊与住院路径作为全骨折FLS运行,药物治疗率为75%,明显高于GHS初级保健的13.8%。
  • 37.8%的患者失访,分析由此识别出多个照护差距与障碍。
  • 分析结果已促使GHS启动项目调整,以缩小这一成熟FLS中报告的照护差距。

核心结论

  • FLS项目采用病例发现策略并处理二级骨折预防,GHS HiROC的绩效及在该骨折人群中启动药物治疗的情况与GHS初级保健低得多的治疗率形成对比,说明需要持续开展FLS照护。
  • 分析结果已促使GHS启动项目调整,旨在缩小这一成熟FLS中报告的照护差距。

研究设计与样本

  • 对2013年至2015年Geisinger健康系统(GHS)门诊HiROC(511例患者)与住院HiROC(1279例患者)的绩效进行回顾性病历审查。
  • HiROC为针对低创伤脆性骨折患者设计的门诊与住院高危骨质疏松门诊项目。

主要发现

  • HiROC路径治疗率为75%,明显优于GHS初级保健(GHS-PCP)照护的13.8%。
  • 大比例患者(37.8%)失访。
  • 分析识别出多个照护差距与障碍,影响理想最佳实践。

关键数值与推荐

  • HiROC治疗率75% vs GHS初级保健治疗率13.8%。
  • 门诊HiROC 511例患者,住院HiROC 1279例患者。
  • 失访患者比例37.8%。

临床怎么用

  • 原文结论指出FLS项目采用病例发现策略并处理二级骨折预防,GHS HiROC的绩效与药物治疗启动情况说明需要持续开展FLS照护。
  • 原文指出分析结果已促使GHS启动项目调整,以缩小报告的照护差距。

局限性

  • 大比例患者(37.8%)失访。
  • 分析识别出多个照护差距与障碍,影响理想最佳实践。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Geisinger Health System (GHS) high-risk osteoporosis clinic (HiROC), which treats patients with low-trauma, fragility fractures, reports their 2013-2015 performance measures in secondary fracture prevention. This fracture liaison service (FLS) pathway treats 75% of high-risk, drug eligible patients, compared to 13.8% in GHS primary care. This performance points to the need for more FLS programs throughout the world. INTRODUCTION: The purpose of this study is to analyze and report ongoing performance measures in outpatient and inpatient high-risk osteoporosis clinic (HiROC) program designed for patients with low-trauma, fragility fractures. METHODS: Retrospective chart review of outpatient HiROC (511 patients) and inpatient HiROC (1279 patients) performance from 2013 to 2015 is reported within Geisinger Health System (GHS). RESULTS: Similar to a prior report, we document that Geisinger's branded outpatient and inpatient HiROC pathways continue to function as an all-fracture FLS. Importantly, this analysis emphasizes the importance of FLS care that HiROC's treatment rate of 75% was markedly superior to GHS-PCP care of 13.8%. However, a large percentage of patients (37.8%) were lost to follow-up care. This led to the identification of multiple care gaps/barriers to ideal best practice. CONCLUSIONS: FLS programs use case finding strategies and address secondary fracture prevention. GHS HiROC's performance and initiation of drug therapy in this fracture patient population contrasts with GHS-PCP care's much lower rate of treatment, documenting the need for ongoing FLS care. Importantly, the results of this analysis have prompted the beginnings of GHS programmatic changes, designed to narrow the reported care gaps in this mature FLS.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Dunn P, Webb D, Olenginski TP, et al. Geisinger high-risk osteoporosis clinic (HiROC): 2013-2015 FLS performance analysis. Osteoporos Int. 2017. PMID: 29063214. doi:10.1007/s00198-017-4270-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。